Camber Pharma Launches Generic Bystolic®

Piscataway, NJ, September 17, 2021– Camber Pharmaceuticals is pleased to announce that it has launched Nebivolol Tablets to their current portfolio, which is the generic version of Bystolic®
Nebivolol Tablets are used to treat hypertension (high blood pressure).
Nebivolol Tablets from Camber are available in 2.5mg-30ct as well as 5mg, 10mg and 20mg in 30 and 90 count bottles.
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection